Neuralink has initiated its first European clinical trial in the UK, partnering with University College London and Newcastle upon Tyne Hospitals. Seven patients, suffering from severe paralysis due to spinal cord injuries or conditions like ALS, will have the N1 chip implanted to control devices with their thoughts. “This study represents a major milestone,” said Professor Harith Akram, highlighting its potential to transform lives of those with neurological disorders.
Neuralink has initiated its first European clinical trial in the UK, partnering with University College London and Newcastle upon Tyne Hospitals. Seven patients, suffering from severe paralysis due to spinal cord injuries or conditions like ALS, will have the N1 chip implanted to control devices with their thoughts. “This study represents a major milestone,” said Professor Harith Akram, highlighting its potential to transform lives of those with neurological disorders.